From Breakthroughs Blog: 2013

 
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
The human face of global health R&D: Natalie Nelson and USAID

The US Agency for International Development (USAID) is the nation’s lead foreign assistance agency.

GHTC
Read More
European action on TB vaccines

In this guest post, Kari Stoever—vice president of External Affairs at Aeras—writes about European support for new vaccines against tuberculosis (TB).

Aeras
Read More
Improving the affordability, availability, and acceptability of health technologies for low- and middle-income countries

In this guest post, Claire Wingfield—product development policy officer at PATH—writes about a new paper she developed for the GHTC that outlines key issues surrounding access to global health products.

PATH
Read More
GHTC
For 2015, the call for innovation is loud and clear

“We cannot solve what we need to solve with existing interventions—we need science and technology,” said Gary Cohen, executive vice president at Becton, Dickinson and Company (BD), at an official side event at the 6th Session of the Opening Working Group on Sustainable Development Goals this week in New York City.

GHTC
Read More
The human face of global health R&D: Ted Prusik and USAID

The US Agency for International Development (USAID) is the nation’s lead foreign assistance agency.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
The end of AIDS requires increased commitments to research

In this guest post, Anupama Dathan—health research assistant for ONE—writes about a new report that examines global commitments to ending the AIDS pandemic.

ONE
Read More
Three key research developments you might have missed from the ASTMH Annual Meeting

In this guest post, Jaclyn Schiff—American Society of Tropical Medicine and Hygiene (ASTMH) Director of Communications—highlights news in global health research presented during the recent ASTMH Annual Meeting.

Read More
PATH/Dan Chang
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Evelyn Hockstin
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
The role of HIV research in ending AIDS: New developments in HIV vaccine and prevention science

In this guest post, Emily Donaldson—program coordinator at AVAC: Global Advocacy for HIV Prevention—writes about an upcoming congressional briefing on November 18 that will highlight the latest in HIV/AIDS research and development.

AVAC
Read More
Impacts of federal budget compromise emerging

After two-and-a-half weeks in limbo, government employees were able to return to work on October 17th—when Congress finally reached a temporary agreement to re-open the government.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New fact sheet outlines the global health R&D pipeline and why US support is so important

In the past, the United States has contributed to important breakthroughs in global health—from the eradication of smallpox to a 74 percent drop in measles deaths worldwide.

GHTC
Read More
PATH/Doune Porter
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
TAG/Hollander Snow Studio
Funding for TB research drops for the first time in eight years

Each year since 2006, TAG has tracked spending on research and development (R&D) for new diagnostics, drugs, and vaccines to improve TB treatment and prevention.

Read More
PATH/ Francesca Holme
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
No more business as usual: USAID’s important role in global health R&D highlighted at Capitol Hill briefing

“You’re in a position to make such a difference and to be innovative with your thinking,” Margaret McCluskey, senior technical advisor at the US Agency for International Development (USAID), said to an audience of Congressional staffers at a briefing yesterday on Capitol Hill.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Budget compromise re-opens the federal government

In this guest post, Jenny Howell—senior policy & advocacy associate at PATH working with the GHTC—writes about the new budget compromise that re-opened the federal government, as well as the effect of the government shutdown on health research programs.

GHTC
Read More
Vaccinate against the brain drain

In this guest post, Elisabeth Wilhelm, senior media specialist at the International AIDS Vaccine Initiative (IAVI), writes about the need to invest in the next generation of researchers and scientists in sub-Saharan Africa.

Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New tool to understand global health regulatory requirements

In this guest post, Tricia Aung—the GHTC’s regulatory associate—writes about a new database that provides easy access to information on global health regulatory information.

GHTC
Read More
PATH/Wendy Stone
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
How did health research fare at the UN General Assembly?

After a busy week of negotiating police barricades and security checks in New York during the United Nations General Assembly (UNGA), we’re back in Washington, DC, with more thinking about the post-2015 development agenda and some reflections about what was heard throughout the week.

GHTC
Read More
What’s ahead on the Hill: An update on the government shutdown and global health R&D programs

In this guest post, Jenny Howell—senior policy & advocacy associate at PATH working with the GHTC—writes about how the government shutdown and budget negotiations in Congress will impact global health research and development (R&D) programs across the federal government.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New technologies in family planning

In this guest post, Dr. Judy Manning from the US Agency for International Development (USAID) and Dr. Zeda Rosenberg from the International Partnership for Microbicides (IPM) discuss the need for new and improved contraceptive options for women worldwide.

Read More
The power to save millions of lives

In this guest post, Rachel Wilson—senior director of Policy and Advocacy at PATH—writes about a new report focused on health innovations for women and children worldwide.

PATH
Read More
A big week for global health, innovation, and the post-2015 development agenda

This week, many GHTC members will be in New York for the sixty-eighth session of the United Nations’ General Assembly (UNGA), where, among other topics, progress toward meeting the Millennium Development Goals (MDGs) will be addressed.

GHTC
Read More
PATH/Mike Wang
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New GHTC resources highlight FDA’s critical role in global health

The GHTC has long stressed that the US Food and Drug Administration (FDA) plays a critical part in efforts to improve global public health.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New paper examines research funding for diseases and conditions of poverty

In this guest post, Claire Wingfield—product development policy officer at PATH—writes about a new paper she developed for the GHTC that outlines key funding challenges and opportunities for global health research and development (R&D).

PATH
Read More
What’s ahead on the Hill: The top five priorities for Congress before the end of 2013

Now that Labor Day has passed and Washington, DC, is starting to cool down, members of Congress are filtering back into town from their August recess travels.

GHTC
Read More
PATH/Lesley Reed
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
More good news for global health R&D as the UK ramps up its investment in product development

Close on the heels of the announcement that Australia is newly investing in global health product development, the United Kingdom last week also revealed that it’s bumping up its longstanding support in this area.

GHTC
Read More
What comes to mind when you think of drug development?

Ever feel like you can’t see the forest for the trees?

GHTC
Read More
Australia’s evolving role in global health R&D

In a notable move for global health research efforts, Australia this week announced funding for four groups developing new drugs, vaccines, and diagnostics for malaria and tuberculosis (TB).

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Elena Pantjushenko
Drug development—It’s not for the faint of heart

Drug discovery and development is a long process. Estimates of the cost to develop a drug up to the point of regulatory approval can range from $150 million to $1.3 billion.

PATH
Read More
PATH/Will Boase
Drug Development 101: A step-by-step guide to drug development

Drug development is a long and complex process.

PATH
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Architect of the Capitol
Federal budget update, Part 2: DoD, CDC, FDA, and NIH

As we discussed yesterday, lawmakers in the House and Senate have been busy with several pieces of legislation that would fund global health and research efforts across the federal government.

GHTC
Read More
Architect of the Capitol
Federal budget update, Part 1: State Department and USAID

Recent weeks have seen a flurry of activity for both the House and Senate appropriations committees.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
House subcommittee bill would cut global health and international development programs

The House State and Foreign Operations (SFOPS) Appropriations Subcommittee on Friday held a hearing on its fiscal year (FY) 2014 budget legislation.

GHTC
Read More
PATH/Matthew Dakin
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
What’s Ahead on the Hill: New bill would improve transparency of US foreign aid programs

Last week, a bipartisan group of legislators in both the House and Senate introduced the Foreign Aid Transparency and Accountability Act of 2013.

GHTC
Read More
Telling the untold story of tuberculosis

In this guest post, Kari Stoever, vice president of External Affairs at Aeras, writes about a new film series that tells the story of the tuberculosis (TB) pandemic.

Aeras
Read More
PATH/Dan Chang
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Senate committee approves spending bill for NIH, CDC

Today, the Senate appropriations committee approved a fiscal year (FY) 2014 appropriations bill that outlines funding levels for the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).

GHTC
Read More
PATH/Mike Wang
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
What’s ahead on the Hill: Congress moving slowly on a federal budget deal

Congress is heading for its July 4 recess next week, having made a few incremental steps toward a fiscal year (FY) 2014 budget for the federal government—including releasing spending levels for several agencies and programs that support global health and research efforts.

GHTC
Read More
India’s new rotavirus vaccine—and the innovative partnership that made it happen

In this guest post, Dr. John Boslego, director of PATH’s Vaccine Development Global Program, writes about an innovative partnership between the United States and India to develop an oral vaccine against rotavirus diarrhea.

PATH
Read More
Improving US programs for the world’s most neglected patients

“A small, modest investment from the US government could truly transform the lives of people around the world and make a serious public health impact,” Rachel Cohen from the Drugs for Neglected Diseases initiative said yesterday at a congressional briefing focused on neglected tropical diseases (NTDs).

GHTC
Read More
Working to protect against the dangers of dengue

In this guest post, Dr. Claire Huang, a researcher with the Centers for Disease Control and Prevention’s (CDC) Division of Vector-Borne Diseases, describes a dengue vaccine candidate developed by her team.

Read More
Rapid, low-cost rabies test offers hope in Haiti

In this guest post, Jessie L. Dyer, MSPH, in the Centers for Disease Control and Prevention’s (CDC) Rabies Program, writes about the agency’s work with partners in Haiti to fight the disease.

Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
The plague dipstick—Bringing the laboratory to the bedside

In this guest post, Dr. Martin Schriefer, chief of the Diagnostic and Reference Activity in the Bacterial Diseases Branch of the Division of Vector-Borne Diseases (DVBD) in Fort Collins, Colo., writes about his laboratory’s development of a new diagnostic tool, the plague dipstick.

Read More
PATH/Wendy Stone
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
21st century tools needed to confront 21st century global health challenges

In this guest post, Dr. Beth P. Bell, director of the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) at the Centers for Disease Control and Prevention (CDC), describes some of her center’s active engagement in global health work.

Read More
New paper offers insights into key challenges facing R&D for diseases of poverty

In this guest post, Claire Wingfield—product development policy officer at PATH—writes about a new paper she developed for the GHTC that outlines key challenges and solutions facing research and development (R&D) for diseases of poverty.

PATH
Read More
IAVI Report
Curtains down for the NEPRC

As animal facilities go, the New England Primate Research Center (NEPRC) had attained a legendary status on the roster of US biomedical research institutions.

IAVI Report and VAX
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New bill would prompt welcome reforms to US foreign assistance programs, including global health R&D

Last week, Reps. Gerry Connolly (D-VA), Karen Bass (D-CA), and Earl Blumenauer (D-OR) introduced the Global Partnerships Act of 2013.

GHTC
Read More
PATH/Evelyn Hockstin
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Evelyn Hockstein
Celebrating vaccines’ past successes and future potential

Through the heroic efforts of infant and childhood global vaccination programs, childhood diseases that once caused millions of deaths across the globe have been thwarted.

Aeras
Read More
New bill would bolster USAID’s role in global health research

Earlier this month, Reps. Albio Sires (D-NJ) and Mario Diaz-Balart (R-FL) introduced the 21st Century Global Health Technology Act, which would make several important and welcome changes to global health research and development (R&D) programs at the US Agency for International Development (USAID).

GHTC
Read More
US government collaborations protect and improve global health

In this guest post, Heather Ignatius, senior policy and advocacy officer at PATH, writes about the important role US agencies play in advancing global health technologies.

PATH
Read More
President’s FY2014 budget has varying news for global health and research programs

Wednesday, the White House released President Obama’s fiscal year (FY) 2014 budget request, which overall has mixed results for global health and research programs.

GHTC
Read More
The Rally for Medical Research: Protecting investments in tropical medicine and global health science

In this guest post, Karen A. Goraleski, executive director of the American Society of Tropical Medicine and Hygiene, writes about the importance of US funding for global health research. This is the third post in a series about this week’s Rally for Medical Research.

Read More
Rally for medical research: Building a grassroots movement to make medical research a higher national priority

In this guest post, Megan Kane, PhD, communications intern, and Morgan McCloskey, global health intern, from Research!America write about a rally earlier this week in support for health science and research.

Research!America
Research!America
Read More
Rally ‘round the research

In this guest post, Regina McEnery—science writer for IAVI Report and VAX—writes about a rally held in Washington, DC, on April 8 to call on federal policymakers to support health research. This post originally appeared on the IAVI Report blog.

IAVI Report and VAX
Read More
Asking the right research questions to achieve global health goals

In this guest post, Kristina Gryboski—technical advisor for the Child Survival and Health Grants Program at the US Agency for International Development (USAID)—writes about the importance of partnerships to advance health research.

Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Eric Becker
Creating partnerships for innovative, high-impact global health products

For more than 30 years, PATH has been working to advance innovative global health solutions. Partnering is a core part of PATH’s strategy and is fundamental to how we develop and deliver high-impact, cost-effective technologies.

PATH
Read More
Budget update: Congress passes budget package for FY2013, while House and Senate introduce starkly different FY2014 budget proposals

Earlier this week, both the House and Senate passed a budget package to fund the government through the remainder of fiscal year (FY) 2013, thereby averting a government shutdown when current funding expires on March 27.

GHTC
Read More
PATH
GHTC members urge Congress to protect global health research funding

Earlier this week, the GHTC and other global health and international development advocates called on the House Appropriations State and Foreign Operations subcommittee to fully fund key programs in the foreign affairs budget.

GHTC
Read More
PATH/Aaron Joel Santos
Film series highlights need for new TB vaccines worldwide

Aeras is excited to share the trailer for a series of short films exposing the underreported global epidemic of TB and the movement for innovation to improve our tools to fight it.

Aeras
Read More
Panel stresses partnerships and long-term support for successful global health research

“I can’t think of a reason why academic scientists should not engage in global health research,” Dr. Dennis Kyle, distinguished university health professor at the University of South Florida, said last week at the Consortium of Universities for Global Health (CUGH) annual conference.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Eric Becker
Where the rubber hits the road: Evidence informing impact for global health

In this guest post, E. Callie Raulfs-Wang –research advisor for the US Agency for International Development’s (USAID) Center for Accelerating Innovation and Impact—writes about the relationship between research and evidence when developing and delivering new global health products.

Read More
Microbicides, vaccines, and TB diagnostics Oh my! What’s new in HIV/AIDS research?

In this guest post, Molly Schmalzbach—public affairs analyst in the Office of HIV/AIDS at the US Agency for International Development (USAID)—discusses the agency’s support for research to develop new HIV/AIDS and tuberculosis (TB) products.

Read More
PATH/Evelyn Hockstein
Global health research and development: Advancing women’s right to health

On this day honoring the political, social, and economic contributions women have made worldwide, nearly 2,000 women will die of AIDS and 790 will perish in pregnancy or childbirth. If we wish to truly advance the health and rights of women globally, we must give them the tools they need to protect their own health.

Read More
New details emerging about sequestration that indicate an uncertain future for global health R&D

Although we’re several days into sequestration, details about the full impact of funding cuts are still hazy. On Friday, the Office of Management and Budget (OMB) released a report to Congress, which details funding cuts required to offset $85 billion in the fiscal year (FY) 2013 budget.

GHTC
Read More
Investing in the future: GHTC congressional briefing highlights compelling benefits of global health research

“I’d be careful not to break something that would be hard to put back together,” Alan Magill—director of Malaria at the Bill & Melinda Gates Foundation—said this week at the GHTC’s annual congressional briefing.

GHTC
Read More
Architect of the Capitol
GHTC 2013 report: Clear steps for policymakers to renew the US legacy in global health R&D

We have long known that Washington is operating under a remarkably unorthodox budgetary process.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
A chorus of voices across the government calls for a solution to sequestration

During last week’s State of the Union address, President Obama called on policymakers to find a solution to the federal budget debate before sequestration—or widespread and indiscriminate cuts to all federal programs—takes place next month.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Obama begins second term with new faces, changing leadership in key global health positions

President Obama officially began his second term in office this week, and will have a host of new faces to work with in Congress and his own administration.

GHTC
Read More
PATH/Doune Porter
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Halting the fiscal cliff: How will the latest budget negotiations impact global health and development?

Going into December 2012, Congress had neither completed its work on the federal budget for fiscal year (FY) 2013 nor decided how to avoid sequestration—widespread and indiscriminate cuts to all federal programs.

GHTC
Read More
PATH/Evelyn Hockstein
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More